Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The koala (Phascolarctos cinereus) is an iconic Australian species that is listed as endangered in the northern parts of its range due to loss of habitat, disease, and road deaths. Diseases contribute significantly to the decline of koala populations, primarily Chlamydia and koala retrovirus. The distribution of these diseases across the species' range, however, is not even. Toll-like receptors (TLRs) play a crucial role in innate immunity by recognising and responding to various pathogens. Variations in TLR genes can influence an individual's susceptibility or resistance to infectious diseases. The aim of this study was to identify koala TLR diversity across the east coast of Australia using 413 re-sequenced genomes at 30 × coverage. We identified 45 single-nucleotide polymorphisms (SNP) leading to 51 alleles within ten TLR genes. Our results show that the diversity of TLR genes in the koala forms four distinct genetic groups, which are consistent with the diversity of the koala major histocompatibility complex (MHC), another key immune gene family. The bioinformatics approach presented here has broad applicability to other threatened species with existing genomic resources.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11608166PMC
http://dx.doi.org/10.1007/s00251-024-01365-5DOI Listing

Publication Analysis

Top Keywords

tlr genes
12
diversity koala
8
koala populations
8
koala
7
spatial variation
4
variation toll-like
4
toll-like receptor
4
diversity
4
receptor diversity
4
populations geographic
4

Similar Publications

Despite the success of antiretroviral therapy in suppressing plasma viremia in people living with human immunodeficiency virus type-1 (HIV-1), persistent viral RNA expression in tissue reservoirs is observed and can contribute to HIV-1-induced immunopathology and comorbidities. Infection of long-lived innate immune cells, such as tissue-resident macrophages and microglia may contribute to persistent viral RNA production and chronic inflammation. We recently reported that de novo cytoplasmic expression of HIV-1 intron-containing RNA (icRNA) in macrophages and microglia leads to MDA5 and MAVS-dependent innate immune sensing and induction of type I IFN responses, demonstrating that HIV icRNA is a pathogen-associated molecular pattern (PAMP).

View Article and Find Full Text PDF

Identification of Immune-Related Long Non-Coding RNAs for Pulpitis Prediction Based on Competing Endogenous RNAs.

Int Dent J

September 2025

Department of Endodontics, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China; Guangdong Engineering Research Center of Oral Restoration and Reconstruction, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou, Chin

Introduction And Aims: Pulpitis is a chronic inflammatory disease affecting oral health. We aim to identify immune-related lncRNAs via bioinformatics analyses and explore their functions through ceRNA networks.

Methods: The expression profiles of 6 patients with pulpitis and 8 normal dental pulp have been obtained from Genome Sequence Archive.

View Article and Find Full Text PDF

Chronic lymphocytic leukemia (CLL) remains incurable despite treatment advances, and a major challenge is that biomarkers that predict response and resistance to current therapies are lacking. We report that activated and proliferating malignant CLL B cells in circulation express PD-1, a protein normally expressed in T cells. PD-1 expression is absent in circulating B cells from healthy controls and nonmalignant B cells from patients with CLL.

View Article and Find Full Text PDF

Food allergy (FA) is an exacerbated immune system response to harmless food antigens following sensitization. The incidence of FA has risen significantly over the past two decades, a trend often attributed to modern lifestyle factors such as dietary patterns, antibiotic use, and urban environments. Sensitization may result from a compromised intestinal barrier caused by inflammatory bowel diseases, genetic predisposition, or a combination of both.

View Article and Find Full Text PDF

Background: Vedolizumab (VDZ) is a monoclonal antibody approved for the treatment of Crohn's disease (CD). Despite its efficacy, non-response to VDZ is common in clinical practice with no clear understanding of how it manifests. Here, we performed an exploratory study characterizing the cellular repertoire of responders and non-responders to VDZ during treatment.

View Article and Find Full Text PDF